Integrative Pharmacovigilance: Monitoring Adverse Events of Herbal, Nutraceutical and Conventional Therapies

Abstract: Integrative pharmacovigilance represents a vital methodology for monitoring adverse events (AEs) linked to both herbal nutraceuticals and conventional therapies. Given the increasing utilization of complementary and alternative medicines (CAMs), it is crucial to ensure the safety of these products. By employing integrated pharmacovigilance strategies for both herbal nutraceuticals and conventional therapies, AEs can be comprehensively captured, data analysed to identify potential safety signals and trends, and associated risks assessed. This methodology empowers healthcare professionals and regulatory agencies to make informed decisions, thereby enhancing patient safety and outcomes. Integrative pharmacovigilance promotes a holistic understanding of the intricate interactions between herbal nutraceuticals and conventional therapies, facilitating more effective risk management and mitigation. The adoption of this approach allows for improved monitoring and management of AEs, alleviating the burden on healthcare systems and benefiting public health. Successful integrative pharmacovigilance necessitates collaboration among various stakeholders, including regulatory agencies, healthcare professionals, and industry partners. By fostering cooperation, the safe use of herbal nutraceuticals and conventional therapies can be assured, thereby enhancing the overall effectiveness of the healthcare system. The integration of pharmacovigilance strategies for these two categories of therapies is essential for safeguarding public health and supporting evidence-based decision-making. By emphasizing integrative pharmacovigilance, the benefits of these products can be optimized while minimizing associated risks, thus ensuring both safety and efficacy. Ultimately, this approach will contribute to a more secure and effective healthcare environment, where patients can confidently utilize herbal nutraceuticals and conventional therapies under the guidance of knowledgeable healthcare professionals. Keywords: Adverse Events Monitoring, Herbal Therapies, Integrative Pharmacovigilance, Public health, Patient safety.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-10
DOI
https://doi.org/10.5281/zenodo.16788935
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrative Pharmacovigilance: Monitoring Adverse Events of Herbal, Nutraceutical and Conventional Therapies

Zenodo (CERN European Organization for Nuclear Research)
Pharmacovigilance and Adverse Drug Reactions
article

Integrative Pharmacovigilance: Monitoring Adverse Events of Herbal, Nutraceutical and Conventional Therapies

article en

Abstract

Abstract: Integrative pharmacovigilance represents a vital methodology for monitoring adverse events (AEs) linked to both herbal nutraceuticals and conventional therapies. Given the increasing utilization of complementary and alternative medicines (CAMs), it is crucial to ensure the safety of these products. By employing integrated pharmacovigilance strategies for both herbal nutraceuticals and conventional therapies, AEs can be comprehensively captured, data analysed to identify potential safety signals and trends, and associated risks assessed. This methodology empowers healthcare professionals and regulatory agencies to make informed decisions, thereby enhancing patient safety and outcomes. Integrative pharmacovigilance promotes a holistic understanding of the intricate interactions between herbal nutraceuticals and conventional therapies, facilitating more effective risk management and mitigation. The adoption of this approach allows for improved monitoring and management of AEs, alleviating the burden on healthcare systems and benefiting public health. Successful integrative pharmacovigilance necessitates collaboration among various stakeholders, including regulatory agencies, healthcare professionals, and industry partners. By fostering cooperation, the safe use of herbal nutraceuticals and conventional therapies can be assured, thereby enhancing the overall effectiveness of the healthcare system. The integration of pharmacovigilance strategies for these two categories of therapies is essential for safeguarding public health and supporting evidence-based decision-making. By emphasizing integrative pharmacovigilance, the benefits of these products can be optimized while minimizing associated risks, thus ensuring both safety and efficacy. Ultimately, this approach will contribute to a more secure and effective healthcare environment, where patients can confidently utilize herbal nutraceuticals and conventional therapies under the guidance of knowledgeable healthcare professionals. Keywords: Adverse Events Monitoring, Herbal Therapies, Integrative Pharmacovigilance, Public health, Patient safety.

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals
Openalex Percentile: Top 55%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Integrative Pharmacovigilance: Monitoring Adverse Events of Herbal, Nutraceutical and Conventional Therapies · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS